Division of Nephrology, Department of Medicine, St. Michael's Hospital, Toronto, Ontario, Canada.
School of Medicine, University College Dublin, Belfield, Dublin, Ireland.
J Ren Nutr. 2018 Mar;28(2):101-109. doi: 10.1053/j.jrn.2017.07.007. Epub 2017 Nov 20.
Frailty among the end-stage renal disease (ESRD) population is highly prevalent and has been associated with mortality. Little is known about the relation of different aspects of body composition, a modifiable risk factor, with the risk of frailty in ESRD population.
One hundred and fifty-one patients including 85 men and 66 women, aged ≥18 years with ESRD who had been receiving conventional maintenance hemodialysis (HD) for at least 3 months were included. Body fat and muscle mass from both bioimpedance spectroscopy and skin-fold thickness and waist circumference as a surrogate of abdominal obesity were measured. Frailty was defined based on Fried's criteria. Health-related quality of life was collected using the RAND version of the Kidney Disease Quality of Life (KDQOL-36) Survey.
We performed single and multiple predictor logistic regression analyses to determine factors associated with frailty. After adjustment for age, sex, and comorbidities, fat mass (both by bioimpedance spectroscopy and anthropometry) and waist circumference, but not muscle mass remained the main predictors of frailty. The odds ratio of frailty in the third tertile compared with the first was 4.97 (1.70-14.55) and 3.84 (1.39-10.61) for fat mass and waist circumference, respectively (P for trends for both <.05). The scores of physical health and kidney disease effect component of quality of life were lower in frail compared with nonfrail patients (40.7 ± 9.2 vs. 33.7 ± 10.2, P < .01 and 66.8 ± 22.4 vs. 51.6 ± 25.7, P < .05 for physical health and effects of disease, respectively).
Frailty, which is associated with poor outcomes in chronic HD patients, is common and predicted by fat mass and waist circumference but not by body mass index and muscle mass. Interventions to modify abdominal obesity, reflected by waist circumference, could potentially lower the incidence of frailty and hence improve the quality of life in the HD population.
终末期肾病(ESRD)患者的衰弱现象非常普遍,并且与死亡率相关。对于身体成分的不同方面(一种可改变的危险因素)与 ESRD 患者衰弱风险之间的关系,我们知之甚少。
共纳入 151 名年龄≥18 岁的患者,包括 85 名男性和 66 名女性,这些患者患有 ESRD,且已接受常规维持性血液透析(HD)至少 3 个月。使用生物电阻抗谱法和皮褶厚度及腰围(作为腹型肥胖的替代指标)测量体脂肪量和肌肉量。根据 Fried 的标准定义衰弱。使用 RAND 版肾脏病生活质量(KDQOL-36)调查问卷收集健康相关生活质量数据。
我们进行了单因素和多因素预测逻辑回归分析,以确定与衰弱相关的因素。在调整年龄、性别和合并症后,脂肪量(生物电阻抗谱法和人体测量法)和腰围仍然是衰弱的主要预测因素,而肌肉量不是。与第一 tertile 相比,第三 tertile 的衰弱的比值比为 4.97(1.70-14.55)和 3.84(1.39-10.61)(两者的趋势 P 值均<.05)。与非衰弱患者相比,衰弱患者的身体健康和肾脏病影响成分的生活质量评分较低(40.7±9.2 比 33.7±10.2,P<.01;66.8±22.4 比 51.6±25.7,P<.05)。
衰弱与慢性 HD 患者的不良结局相关,在该人群中很常见,可通过体脂肪量和腰围预测,但不能通过体重指数和肌肉量预测。针对腰围反映的腹型肥胖进行干预可能会降低衰弱的发生率,从而提高 HD 患者的生活质量。